U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159581) titled 'Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CT' on Aug. 22.
Brief Summary: The primary objective of this study is to investigate the effect of gene therapy (UX704) on copper distribution and excretion in Wilson disease patients. The effect is investigated using 64Cu positron emission tomography scans combined with a CT scan.
Study Start Date: July 08
Study Type: OBSERVATIONAL
Condition:
Wilson Disease
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Thomas Damgaard Sandahl
Information provided by (Responsible Party): Thomas Damgaard Sandahl, University of Aarhus
Published by HT Digital Content Services with per...